trastuzumab,pertuzumab
roche
['breast', 'pertuzumab', 'trastuzumab,(-trastuzumab deruxtecan),(-trastuzumab-deruxtecan)', 'phergain']
new results from the phase 2 phergain trial were just presented at #asco23. ct scanning after neoadjuvant trastuzumab and pertuzumab treatment is able to identify patients who can avoid chemo for their her2+ #breastcancer, which leads to fewer side effects from therapy. 
A force united by a promise to end breast cancer, funding groundbreaking research, community health & advocacy programs globally.
https://t.co/dvoS7vv1mZ